Latest Dilution News

Discovery Alaska Limited has announced the termination of its mining lease for the Vinasale Project, choosing to preserve capital and concentrate on its flagship Chulitna Project alongside exploring new opportunities.

Pantoro Gold is set to become debt free by repaying its US$6.26 million Convertible Loan Facility ahead of schedule, reducing shareholder dilution and saving on interest payments.

HitIQ Limited's trading suspension has been lifted following its announcement of a proposed capital raising, signaling renewed investor interest and potential growth opportunities.

HITIQ Ltd has successfully completed a $680,000 placement and launched a $2.92 million rights issue, positioning the company to fund its strategic shift towards the consumer market and expand its footprint in the US.

Alice Queen Limited has voluntarily suspended trading of its shares on the ASX as it finalises a proposed capital raising, with an announcement expected by 5 May 2025.

Sparc Technologies has successfully raised up to A$2.7 million through a share placement and a Share Purchase Plan, positioning the company to accelerate commercialisation of its graphene additive ecosparc and support its green hydrogen pilot projects.

Dreadnought Resources has partnered with Teck Resources in a $15 million farm-in and joint venture to advance the Money Intrusion Ni-Cu-Co-PGE prospect at Mangaroon, WA. This deal brings a major global player into the project, accelerating exploration while preserving Dreadnought’s gold ambitions.

Anatara Lifesciences has obtained a $400,000 loan advance from a major shareholder group against its estimated R&D tax refund for the first half of FY2025, providing crucial funding to support ongoing clinical trials and product development without immediate capital raising.

Burgundy Diamond Mines reported a challenging Q1-2025 with lower ore mined and revenue, yet continues to progress development at Point Lake and Misery mines while strengthening its financial position.

AdAlta Limited has made significant progress in its 'East to West' cellular immunotherapy strategy by executing three CAR-T term sheets and completing technical due diligence, while implementing cost-cutting measures and seeking new capital amid a tough financing environment.

Horseshoe Metals Limited has reignited development at its Horseshoe Lights Copper-Gold Project, securing a $4 million convertible loan and entering a strategic agreement with Melody Gold to process gold surface materials, positioning the company for early cash flow and expanded exploration.

Recce Pharmaceuticals reports strong Phase II clinical trial results for its topical anti-infective R327G, achieving a 93% efficacy rate in treating ABSSSI, alongside a significant capital raise to fund upcoming Phase III trials.